The U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) continues to drive medical progress in 2025, marking another transformative year for global drug development. The agency’s annual compilation of FDA Innovative Drugs 2025 reflects a rapidly evolving pharmaceutical ecosystem. Characterized by record numbers of therapies targeting rare diseases, a surge … Continue reading FDA Innovative Drugs 2025: Rare-Disease Therapies, Antibody Breakthroughs, and Global Innovation Momentum